The Patent Finder
US

Therapeutic Formulation for Reduced Drug Side Effects

US 10,463,633 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 25, 2031 · High confidence

Filed Apr 25, 2011 as application 13/093,662 · Granted Nov 5, 2019
Base term plus 338 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2011 2031
Clock starts
Apr 25, 2011
Term ends
Apr 25, 2031
Granted
Nov 5, 2019
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
338
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,511,037.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 338 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 25, 2011, when this application, 13/093,662, was filedApr 25, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+338 days, USPTO patent term adjustment recordMar 28, 2032High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,511,037)capped to Apr 25, 2031High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 25, 2031High confidence

This family

US 10,463,633this patent
Apr 2031
Apr 2031
US 9,511,037In force
Apr 2031
Apr 2031
US 10,912,744In force
Apr 2031
Apr 2031
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 20, 2012
Reel 28815, frame 281
Desai, SubhashGenco Sciences LLCAssignment of Assignor's Interest
Oct 10, 2017
Reel 43824, frame 734
Genco Sciences LLCKempharm, Inc.Assignment of Assignor's Interest
Feb 23, 2024
Reel 66664, frame 108
Kempharm, Inc.Zevra Therapeutics, Inc.Change of Name
Apr 8, 2024
Reel 67040, frame 637
Zevra Therapeutics, Inc.Alter Domus (US) LLCSecurity Interest
Mar 13, 2026
Reel 75080, frame 907
Alter Domus (US) LLCZevra Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited